- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03366285
Bonding Quality and Gene Expression in Fullterm Infants Compared to Late Preterm Infants and Preterm Infants With Early Skin to Skin or Visual Contact
November 19, 2020 updated by: Katrin Mehler, University of Cologne
Bonding Quality and Gene Expression of Key Molecules Involved in Stress Response in Fullterm Infants Compared to Late Preterm Infants and Preterm Infants With Early Skin to Skin Contact or Visual Contact at Age 6 to 8 Years
Recent research has identified differences in the quality of mother-child interaction and gene expression of six key molecules involved in stress response and neurobehavioral development in preterm infants (born <32 weeks of gestational age) with early skin to skin contact after birth compared to infants with visual contact at six months corrected age.
We hypothesize that these differences are still identifiable at the age of 6 to 8 years and that quality of bonding in preterm infants born <32 weeks of gestation differs significantly from late preterm infants and full-term infants.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Quality of bonding in former preterm infants born 2012 to 2015 who participated in the "delivery room skin to skin study" (deisy), moderate to late preterm infants born 2010 to 2011 who participated in the "trauma and depression in late preterm parents study" (TraDelPP) and full-term infants at 6 to 8 years of age is assessed using the German version of the attachment story completion task (ASCT).
Additionally, gene expression of six key molecules involved in stress response and neurobehavioral development (the corticotropin releasing hormone receptor 1 and 2 genes (CRHR1 and CRHR2), arginine vasopressin gene (AVP), the glucocorticoid receptor gene (NR3C1), the serotonin receptor 2A gene (HTR2A), and the serotonin transporter gene (SLC6A4)) are quantified in in mucosal epithelial cells from buccal swabs of children of all four groups.
Maternal and infant co-factors such as maternal depression, perceived social support, parental stress, infant health development and behavior are assessed by self-reporting questionnaires.
Study Type
Observational
Enrollment (Anticipated)
80
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Katrin Mehler, MD
- Phone Number: 00492214785998
- Email: Katrin.Mehler@uk-koeln.de
Study Contact Backup
- Name: Angela Kribs, MD
- Phone Number: 004922147885665
- Email: Angela.Kribs@uk-koeln.de
Study Locations
-
-
-
Cologne, Germany, 50937
- Recruiting
- University of Cologne, Medical Faculty
-
Contact:
- Katrin Mehler, MD
- Phone Number: 00492214785998
- Email: Katrin.Mehler@uk-koeln.de
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 years to 9 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Former preterm infants and full-term infants at 6 to 8 years of age
Description
Inclusion Criteria:
- first child, singleton, former participant of "deisy" or "TraDelPP" study for preterm infants, uncomplicated vaginal birth for fullterm infants
Exclusion Criteria:
- Maternal mental health problems, resuscitation after birth, malformations or severe underlying disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Fullterm infants
Quality of bonding is assessed at 6 to 8 years of age using the attachment story completion task.
Infants are recruited from the local elementary school.
|
Bonding quality
Other Names:
|
Moderate to late preterm infants
Bonding quality is assessed at 6 to 8 years of age using the attachment story completion task.
Infants are recruited from former participants of the "trauma and depression in late preterm parents study" (TraDelPP) conducted 2010 to 2011.
|
Bonding quality
Other Names:
|
Preterm infants with skin to skin contact
Bonding quality is assessed at 6 to 8 years of age using the attachment story completion task.
Infants are recruited from former participants of the "delivery room skin to skin study" (deisy) who were randomized into the skin to skin contact group.
The study was conducted from 2012 to 2015.
|
Bonding quality
Other Names:
|
Preterm infants with visual contact
Bonding quality is assessed at 6 to 8 years of age using the attachment story completion task.
Infants are recruited from former participants of the "delivery room skin to skin study" (deisy) who were randomized into the visual contact group.
The study was conducted from 2012 to 2015.
|
Bonding quality
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Bonding quality
Time Frame: 6 to 8 years of age
|
Quality of mother infant bonding is assessed with the German version of the Attachment Story Completion Task (Bretherton and Ridgeway 1990)
|
6 to 8 years of age
|
Gene expression
Time Frame: 6 to 8 years of age
|
Quantification of gene expression of six key molecules involved in stress response and neurobehavioural development
|
6 to 8 years of age
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Maternal depression
Time Frame: 6 to 8 years of age
|
Maternal depression is assessed with the German long form of the Center for Epidemiological Studies Depression Scale (CES-D).
|
6 to 8 years of age
|
Maternal perceived social support
Time Frame: 6 to 8 years of age
|
Perceived social support is assessed with the short version of the F-SozU scale (F-SozU K-22).
|
6 to 8 years of age
|
Maternal parenting stress
Time Frame: 6 to 8 years of age
|
For the assessment of parenting stress the German version of the Parenting Stress Index (PSI) is used
|
6 to 8 years of age
|
Infant health and development
Time Frame: 6 to 8 years of age
|
Infant health and development are assessed by a self-reporting questionnaire and the results from compulsory pediatric medical checkups.
The questionnaire for assessment of infant health and development was designed for the KIGGS study (a large German cohort study on infant´s health)
|
6 to 8 years of age
|
Infant behavior
Time Frame: 6 to 8 years of age
|
For assessment of infant behavior the German version of the Child Behavior Checklist (CBCL) is used.
|
6 to 8 years of age
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2018
Primary Completion (Anticipated)
April 1, 2021
Study Completion (Anticipated)
December 1, 2021
Study Registration Dates
First Submitted
November 27, 2017
First Submitted That Met QC Criteria
December 7, 2017
First Posted (Actual)
December 8, 2017
Study Record Updates
Last Update Posted (Actual)
November 20, 2020
Last Update Submitted That Met QC Criteria
November 19, 2020
Last Verified
November 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 17-075
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Premature Infant
-
University of MiamiPontificia Universidad Catolica de ChileTerminated
-
Johnson & Johnson Pharmaceutical Research & Development...TerminatedInfant, Premature | Infant, Newborn
-
NICHD Neonatal Research NetworkNational Center for Research Resources (NCRR)CompletedSepsis | Infant, Small for Gestational Age | Infant, Premature | Infant, Low Birth Weight | Infant, NewbornUnited States
-
Aydin Adnan Menderes UniversityCompletedNursing Caries | Infant Development | Premature Infant Disease | Patient ComfortTurkey
-
University of VirginiaRecruitingDevelopment, Infant | Premature Infant DiseaseUnited States
-
Universidad de LeónCompletedPremature Birth | Premature Infant | Massage | Preterm Infant
-
Istituto Giannina GasliniEubrainRecruiting
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaCompletedPreterm Birth | Cerebral Autoregulation | Premature Infant DiseaseItaly
-
Sun Yat-sen UniversityRecruitingPremature Infant DiseaseChina
-
Instituto Nacional de Perinatologia Isidro Espinosa...UnknownImmune System Diseases | Premature Infant Disease | Immunoglobulin DeficiencyMexico